• Probenecid: MRP Inhibitor Empowering Tumor & Neuroprotect...

  2025-10-24

  Probenecid stands out as a dual-action MRP inhibitor and pannexin-1 channel blocker, revolutionizing workflows in multidrug resistance and neuroprotection studies. Its unique ability to sensitize tumor cells and modulate inflammatory pathways unlocks new precision for both cancer and neuroscience research.

• Calpain Inhibitor I (ALLN): Precision Tools for Apoptosis...

  2025-10-23

  Calpain Inhibitor I (ALLN) empowers researchers to dissect protease-driven cellular processes across apoptosis, inflammation, and ischemia-reperfusion injury with unmatched specificity. Its robust inhibition profile, cell permeability, and compatibility with machine learning-enabled phenotypic workflows distinguish ALLN as a foundational reagent for advanced translational research.

• Z-DEVD-FMK: Irreversible Caspase-3 Inhibitor for Apoptosi...

  2025-10-22

  Z-DEVD-FMK’s dual-action inhibition of caspases and calpain uniquely empowers researchers investigating apoptosis, neuroprotection, and cell death. Its cell-permeability and irreversible binding streamline workflows in cancer research and neurodegenerative disease models, delivering robust and reproducible results where specificity and mechanistic insight are critical.

• Phenylmethanesulfonyl Fluoride (PMSF): Protease Inhibitio...

  2025-10-21

  Explore the advanced role of phenylmethanesulfonyl fluoride (PMSF), a leading irreversible serine protease inhibitor, in safeguarding protein integrity for apoptosis, cell signaling, and neuropathy research. Discover unique mechanistic insights and translational applications beyond standard protein extraction workflows.

169 records 12/12 page Previous First page 上5页 1112